EFPIA Laments 'Unfortunate' Exclusions From ICH Guide On Nonclinical Pediatric Safety
Executive Summary
Europe’s research-based pharmaceutical industry has suggested changes to the draft ICH S11 guideline on nonclinical safety studies for supporting pediatric development programs.